Connection

Christina Johnson to BH3 Interacting Domain Death Agonist Protein

Back to Details
This is a "connection" page, showing publications Christina Johnson has written about BH3 Interacting Domain Death Agonist Protein.
Christina Johnson
Connection Strength
0.025
BH3 Interacting Domain Death Agonist Protein
  1. Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. Cancer Gene Ther. 2002 Feb; 9(2):164-72.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.